Janux Therapeutics, Inc. - stock earnings
JANX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -11.6 million USD | 2.5 million USD |
| 2023Q2 | -17.5 million USD | 1.1 million USD |
| 2023Q1 | -14.2 million USD | 2.0 million USD |
| 2022Q4 | -11.3 million USD | 2.8 million USD |
| 2022Q3 | -14.0 million USD | 1.8 million USD |
| 2022Q2 | -16.5 million USD | 2.4 million USD |
| 2022Q1 | -13.1 million USD | 1.6 million USD |
| 2021Q4 | -13.4 million USD | 1.6 million USD |
| 2021Q3 | -10.8 million USD | 1.2 million USD |
| 2021Q2 | -6.2 million USD | 482000 USD |
| 2021Q1 | -2.3 million USD | 380000 USD |
| 2020Q4 | -1.7 million USD | ? USD |
| 2020Q3 | -1.3 million USD | ? USD |
| 2020Q2 | -2.5 million USD | ? USD |
| 2020Q1 | -1.4 million USD | ? USD |
JANX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -62.6 million USD | 8.5 million USD |
| 2022 | -54.2 million USD | 8.6 million USD |
| 2021 | -32.6 million USD | 3.6 million USD |
| 2020 | -5.3 million USD | 380000 USD |
| 2019 | -4.2 million USD | ? USD |
JANX
Price: $64.78
52 week price:
Earnings Per Share: -1.32 USD
P/E Ratio: -5.66
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 219876
Market Capitalization: 2.1 billion